Metabolism, Activity, and Targeting of D- and L-2-Hydroxyglutarates
Open accessAbstract
Isocitrate dehydrogenases (IDH1/2) are frequently mutated in multiple types of human cancer, resulting in neomorphic enzymes that convert α-ketoglutarate (α-KG) to 2-hydroxyglutarate (2-HG). The current view on the mechanism of IDH mutation holds that 2-HG acts as an antagonist of α-KG to competitively inhibit the activity of α-KG-dependent dioxygenases, including those involved in histone and DNA demethylation. Recent studies have implicated 2-HG in activities beyond epigenetic modification. Multiple enzymes have been discovered that lack mutations but that can nevertheless produce 2-HG promiscuously under hypoxic or acidic conditions. Therapies are being developed to treat IDH-mutant cancers by targeting either the mutant IDH enzymes directly or the pathways sensitized by 2-HG.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Almost all IDH1/2 mutations occur in a few unique locations in the active site, resulting in neomorphic activity converting α-KG to D-2-HG.
“Remarkably, almost all IDH1/2 mutations occur in a few unique locations in the active site of the enzymes, which results in the acquirement of a neomorphic enzymatic activity converting α-KG to the oncometabolite D-2-HG118-120.”
From Coupling Krebs cycle metabolites to signalling in immunity and cancer (2018) · cites this paper as [119]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857 · see citing works
<i>IDH1</i> and <i>IDH2</i> Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847 · see citing works
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
The Cancer Genome Atlas Research Network (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301689 · Cited by 5,078 · see citing works
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154 · see citing works
Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.
Kaelin, W. G., & Ratcliffe, P. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.009 · Cited by 3,251 · cited 1× · see citing works
“EGLN/PHD-mediated regulation of HIF-1α is the core of ancient oxygen-monitoring machinery used by metazoans from the nematode Caenorhabditis elegans to humans [129].”
BackgroundComprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
The Cancer Genome Atlas Research Network (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1402121 · Cited by 3,148 · see citing works
Xu, W., Yang, H., Liu, Y., Yang, Y., Wang, P., Kim, S.-H., Ito, S., Yang, C., Wang, P., Xiao, M.-T., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.12.014 · Cited by 2,875 · see citing works
Self-citationFigueroa, M. E., Abdel-Wahab, O., Lu, C., Ward, P. S., Patel, J., Shih, A., Li, Y., Bhagwat, N., Vasanthakumar, A., Fernandez, H. F., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.11.015 · Cited by 2,766 · see citing works
Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
Noushmehr, H., Weisenberger, D. J., Diefes, K., Phillips, H. S., Pujara, K., Berman, B. P., Pan, F., Pelloski, C. E., Sulman, E. P., Bhat, K. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.03.017 · Cited by 2,337 · see citing works
Recurring mutations found by sequencing an acute myeloid leukemia genome
Mardis, E. R., Ding, L., Dooling, D. J., Larson, D. E., McLellan, M. D., Chen, K., Koboldt, D. C., Fulton, R. S., Delehaunty, K. D., McGrath, S. D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0903840 · Cited by 2,219 · see citing works
Ceccarelli, M., Barthel, F. P., Malta, T. M., Sabedot, T. S., Salama, S. R., Murray, B. A., Morozova, O., Newton, Y., Radenbaugh, A., Pagnotta, S. M., et al. (2016) · Cell · doi:10.1016/j.cell.2015.12.028 · Cited by 2,178 · see citing works
Ward, P. S., Patel, J., Wise, D. R., Abdel-Wahab, O., Bennett, B. D., Coller, H. A., Cross, J. R., Fantin, V. R., Hedvat, C. V., Perl, A. E., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.01.020 · Cited by 2,020 · see citing works
IDH mutation impairs histone demethylation and results in a block to cell differentiation
Lu, C., Ward, P. S., Kapoor, G. S., Rohle, D., Turcan, S., Abdel-Wahab, O., Edwards, C. R., Khanin, R., Figueroa, M. E., Melnick, A., et al. (2012) · Nature · doi:10.1038/nature10860 · Cited by 1,985 · see citing works
Glioma Groups Based on 1p/19q, IDH , and TERT Promoter Mutations in Tumors
Eckel‐Passow, J. E., Lachance, D. H., Molinaro, A. M., Walsh, K. M., Decker, P. A., Sicotte, H., Pekmezci, M., Rice, T., Kosel, M., Smirnov, I. V., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1407279 · Cited by 1,981 · see citing works
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
Turcan, S., Rohle, D., Goenka, A., Walsh, L. A., Fang, F., Yilmaz, E., Campos, C., Fabius, A. W. M., Lu, C., Ward, P. S., et al. (2012) · Nature · doi:10.1038/nature10866 · Cited by 1,974 · see citing works
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
Patel, J. P., Gönen, M., Figueroa, M. E., Fernandez, H. F., Sun, Z., Racevskis, J., Vlierberghe, P. V., Dolgalev, I., Thomas, S., Aminova, O., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112304 · Cited by 1,936 · see citing works
Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
Possemato, R., Marks, K. M., Shaul, Y. D., Pacold, M. E., Kim, D., Birsoy, K., Sethumadhavan, S., Woo, H.-K., Jang, H. G., Jha, A. K., et al. (2011) · Nature · doi:10.1038/nature10350 · Cited by 1,683 · see citing works
TET-mediated active DNA demethylation: mechanism, function and beyond
Wu, X., & Zhang, Y. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2017.33 · Cited by 1,661 · see citing works
Enzyme promiscuity: A mechanistic and evolutionary perspective
Tawfik, O. K. A. D. S. (2010) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-030409-143718 · Cited by 1,355 · see citing works
JmjC-domain-containing proteins and histone demethylation
Klose, R. J., Kallin, E. M., & Zhang, Y. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1945 · Cited by 1,290 · see citing works
Metabolic Regulation of T Lymphocytes
MacIver, N. J., Michalek, R. D., & Rathmell, J. C. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095956 · Cited by 1,244 · see citing works
An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells
Rohle, D., Popovici-Muller, J., Palaskas, N., Turcan, S., Grommes, C., Campos, C., Tsoi, J., Clark, O., Oldrini, B., Komisopoulou, E., et al. (2013) · Science · doi:10.1126/science.1236062 · Cited by 1,153 · see citing works
Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis
Locasale, J. W., Grassian, A. R., Melman, T., Lyssiotis, C. A., Mattaini, K. R., Bass, A. J., Heffron, G., Metallo, C. M., Muranen, T., Sharfi, H., et al. (2011) · Nature Genetics · doi:10.1038/ng.890 · Cited by 1,120 · see citing works
Glioma-Derived Mutations in <i>IDH1</i> Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α
Zhao, S., Lin, Y., Xu, W., Jiang, W., Zha, Z., Wang, P., Yu, W., Li, Z., Gong, L., Peng, Y., et al. (2009) · Science · doi:10.1126/science.1170944 · Cited by 1,119 · see citing works
Self-citationRadiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma
Buckner, J. C., Shaw, E. G., Pugh, S. L., Chakravarti, A., Gilbert, M. R., Barger, G. R., Coons, S., Ricci, P., Bullard, D., Brown, P. D., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1500925 · Cited by 1,064 · see citing works
The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases
Chowdhury, R., Yeoh, K. K., Tian, Y., Hillringhaus, L., Bagg, E. A., Rose, N. R., Leung, I. K. H., Li, X. S., Woon, E. C. Y., Yang, M., et al. (2011) · The EMBO Reports · doi:10.1038/embor.2011.43 · Cited by 1,035 · see citing works
IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas
Watanabe, T., Nobusawa, S., Kleihues, P., & Ohgaki, H. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080958 · Cited by 1,027 · see citing works
Wise, D. R., Ward, P. S., Shay, J. E. S., Cross, J. R., Gruber, J. J., Sachdeva, U. M., Platt, J. M., DeMatteo, R. G., Simon, M. C., & Thompson, C. B. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117773108 · Cited by 975 · see citing works
New nomenclature for chromatin-modifying enzymes
Allis, C. D., Berger, S. L., Cote, J., Dent, S., Jenuwien, T., Kouzarides, T., Pillus, L., Reinberg, D., Shi, Y., Shiekhattar, R., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.039 · Cited by 957 · see citing works
TETonic shift: biological roles of TET proteins in DNA demethylation and transcription
Pastor, W. A., Aravind, L., & Rao, A. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3589 · Cited by 897 · cited 1× · see citing works
“DNA repair enzymes such as glycosylases remove 5caC, which is then replaced by unmethylated cytosine [124,125].”
BackgroundMutational landscape and clonal architecture in grade II and III gliomas
Suzuki, H., Aoki, K., Chiba, K., Sato, Y., Shiozawa, Y., Shiraishi, Y., Shimamura, T., Niida, A., Motomura, K., Ohka, F., et al. (2015) · Nature Genetics · doi:10.1038/ng.3273 · Cited by 831 · see citing works
Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation
Wang, F., Travins, J., DeLaBarre, B., Penard-Lacronique, V., Schalm, S., Hansen, E., Straley, K., Kernytsky, A., Liu, W., Gliser, C., et al. (2013) · Science · doi:10.1126/science.1234769 · Cited by 804 · see citing works
Oxidative demethylation by Escherichia coli AlkB directly reverts DNA base damage
Trewick, S. C., Henshaw, T. F., Hausinger, R. P., Lindahl, T. L., & Sedgwick, B. (2002) · Nature · doi:10.1038/nature00908 · Cited by 762 · see citing works
Gross, S., Cairns, R. A., Minden, M. D., Driggers, E. M., Bittinger, M. A., Jang, H. G., Sasaki, M., Jin, S., Schenkein, D. P., Su, S. M., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092506 · Cited by 736 · see citing works
Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation
Koivunen, P., Lee, S., Duncan, C. G., Lopez, G., Lu, G., Ramkissoon, S., Losman, J. A., Joensuu, P., Bergmann, U., Gross, S., et al. (2012) · Nature · doi:10.1038/nature10898 · Cited by 727 · see citing works
A new pathway for DNA repair in Escherichia coli
Samson, L. D., & Cairns, J. (1977) · Nature · doi:10.1038/267281a0 · Cited by 704 · see citing works
Losman, J.-A., Looper, R. E., Koivunen, P., Lee, S., Schneider, R. K., McMahon, C., Cowley, G. S., Root, D. E., Ebert, B. L., & Kaelin, W. G. (2013) · Science · doi:10.1126/science.1231677 · Cited by 703 · see citing works
Hypoxia-inducible factors enhance the effector responses of CD8(+) T cells to persistent antigen
Doedens, A. L., Phan, A. T., Stradner, M. H., Fujimoto, J. K., Nguyen, J. V., Yang, E., Johnson, R. S., & Goldrath, A. W. (2013) · Nature Immunology · doi:10.1038/ni.2714 · Cited by 660 · cited 1× · see citing works
“CD8+ T cells, the cytotoxic T lymphocytes that kill cancer cells, traffic to hypoxic areas in tumors and inflamed tissues, and HIF-1α mediates this migration [90,91].”
BackgroundEnzyme promiscuity: mechanism and applications
Hult, K., & Berglund, P. (2007) · Trends in biotechnology · doi:10.1016/j.tibtech.2007.03.002 · Cited by 637 · see citing works
Tumour hypoxia causes DNA hypermethylation by reducing TET activity
Thienpont, B., Steinbacher, J., Zhao, H., D’Anna, F., Kuchnio, A., Ploumakis, A., Ghesquière, B., Van Dyck, L., Boeckx, B., Schoonjans, L., et al. (2016) · Nature · doi:10.1038/nature19081 · Cited by 635 · cited 1× · see citing works
“A recent study found that tumor hypoxia broadly reduced the activity of TET dioxygenases and caused DNA hypermethylation [71].”
BackgroundAlkB-mediated oxidative demethylation reverses DNA damage in Escherichia coli
Falnes, P. Ø., Johansen, R., & Seeberg, E. C. (2002) · Nature · doi:10.1038/nature01048 · Cited by 617 · see citing works
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2010) · Nature · doi:10.1038/nature09132 · Cited by 613 · see citing works
Finlay, D. K., Rosenzweig, E., Sinclair, L. V., Feijoo-Carnero, C., Hukelmann, J. L., Rolf, J., Panteleyev, A. A., Okkenhaug, K., & Cantrell, D. A. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20112607 · Cited by 596 · see citing works
Isocitrate dehydrogenase 1 and 2 mutations induce BCL-2 dependence in acute myeloid leukemia
Chan, S. M., Thomas, D., Corces, M. R., Xavy, S., Rastogi, S., Hong, W., Zhao, F., Medeiros, B. C., Tyvoll, D. A., & Majeti, R. (2015) · Nature Medicine · doi:10.1038/nm.3788 · Cited by 580 · see citing works
Sulkowski, P. L., Corso, C. D., Robinson, N. D., Scanlon, S. E., Purshouse, K. R., Bai, H., Liu, Y., Sundaram, R. K., Hegan, D. C., Fons, N. R., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aal2463 · Cited by 556 · see citing works
Hypoxia Induces Production of L-2-Hydroxyglutarate
Intlekofer, A. M., Dematteo, R. G., Venneti, S., Finley, L. W. S., Lu, C., Judkins, A. R., Rustenburg, A. S., Grinaway, P. B., Chodera, J. D., Cross, J. R., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.06.023 · Cited by 513 · see citing works
Catalytic Mechanisms of Fe(II)- and 2-Oxoglutarate-dependent Oxygenases
Martinez, S., & Hausinger, R. P. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.648691 · Cited by 499 · see citing works
Yen, K., Travins, J., Wang, F., David, M. D., Artin, E., Straley, K., Padyana, A., Gross, S., DeLaBarre, B., Tobin, E., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-1034 · Cited by 471 · cited 1× · see citing works
“AG-221 inhibited D-2-HG production and induced the differentiation of IDH2mutated primary leukemia cells; it suppressed D-2-HG production and extended survival in tumor xenograft models [113].”
BackgroundIDH1andIDH2Mutations in Tumorigenesis: Mechanistic Insights and Clinical Perspectives
Yang, H., Ye, D., Guan, K., & Xiong, Y. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1773 · Cited by 459 · see citing works
Self-citationProfiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome
Reitman, Z. J., Jin, G., Karoly, E. D., Spasojevic, I., Yang, J., Kinzler, K. W., He, Y., Bigner, D. D., Vogelstein, B., & Yan, H. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019393108 · Cited by 449 · see citing works
Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma
Chaisaingmongkol, J., Budhu, A., Dang, H., Rabibhadana, S., Pupacdi, B., Kwon, S. M., Forgues, M., Pomyen, Y., Bhudhisawasdi, V., Lertprasertsuke, N., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.05.009 · Cited by 434 · see citing works
Extreme vulnerability of IDH1 mutant cancers to NAD+ depletion
Tateishi, K., Wakimoto, H., Iafrate, A. J., Tanaka, S., Loebel, F., Lelic, N., Wiederschain, D., Bedel, O., Deng, G., Zhang, B., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.11.006 · Cited by 433 · see citing works
S-2-hydroxyglutarate regulates CD8(+) T-lymphocyte fate
Tyrakis, P. A., Palazon, A., Macias, D., Lee, K. L., Phan, A. T., Veliça, P., You, J., Chia, G. S., Sim, J., Doedens, A., et al. (2016) · Nature · doi:10.1038/nature20165 · Cited by 433 · see citing works
MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis
Terunuma, A., Putluri, N., Mishra, P., Mathé, E. A., Dorsey, T. H., Yi, M., Wallace, T. A., Issaq, H. J., Zhou, M., Killian, J. K., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71180 · Cited by 428 · see citing works
Fedeles, B. I., Singh, V., Delaney, J. C., Li, D., & Essigmann, J. M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.656462 · Cited by 416 · see citing works
Reversal of DNA alkylation damage by two human dioxygenases
Duncan, T., Trewick, S. C., Koivisto, P., Bates, P. A., Lindahl, T. L., & Sedgwick, B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.262589799 · Cited by 414 · see citing works
Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas
Kohanbash, G., Carrera, D. A., Shrivastav, S., Ahn, B. J., Jahan, N., Mazor, T., Chheda, Z. S., Downey, K., Watchmaker, P. B., Beppler, C., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90644 · Cited by 413 · see citing works
Mutant IDH1 regulates the tumor-associated immune system in gliomasPreprint
Amankulor, N., Kim, Y., Arora, S., Kargl, J., Szulzewsky, F., Hanke, M. L., Margineantu, D. H., Rao, A., Bolouri, H., Delrow, J. J., et al. (2017) · Genes & Development · doi:10.1101/gad.294991.116 · Cited by 403 · see citing works
Cairncross, J. G., Wang, M., Jenkins, R. B., Shaw, E. G., Giannini, C., Brachman, D. G., Buckner, J. C., Fink, K., Souhami, L., Laperrière, N., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.3726 · Cited by 400 · see citing works
Wang, P., Dong, Q., Zhang, C., Kuan, P.-F., Liu, Y., Jeck, W. R., Andersen, J. B., Jiang, W., Savich, G. L., Tan, T.-X., et al. (2013) · Oncogene · doi:10.1038/onc.2012.315 · Cited by 399 · see citing works
Self-citationInhibition of 2-oxoglutarate dependent oxygenases
Rose, N. R., McDonough, M. A., King, O. N. F., Kawamura, A., & Schofield, C. J. (2011) · Chemical Society Reviews · doi:10.1039/c0cs00203h · Cited by 395 · see citing works
Metabolic control of TH17 and induced Treg cell balance by an epigenetic mechanism
Xu, T., Stewart, K. M., Wang, X., Liu, K., Xie, M., Ryu, J. K., Li, K., Ma, T., Wang, H., Ni, L., et al. (2017) · Nature · doi:10.1038/nature23475 · Cited by 395 · see citing works
Oldham, W. M., Clish, C. B., Yang, Y., & Loscalzo, J. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.06.021 · Cited by 364 · cited 2× · see citing works
“Subsequent metabolomics studies discovered that hypoxia increased α-KG and L-2-HG in a broad range of transformed human cell lines [55,56].”
BackgroundSuccessful chemotherapy for recurrent malignant oligodendroglioma
Cairncross, J. G., & Macdonald, D. R. (1988) · Annals of Neurology · doi:10.1002/ana.410230408 · Cited by 345 · see citing works
The mitochondrial respiratory chain is essential for haematopoietic stem cell function
Ansó, E., Weinberg, S. E., Diebold, L. P., Thompson, B. J., Malinge, S., Schumacker, P. T., Liu, X., Zhang, Y., Shao, Z., Steadman, M., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3529 · Cited by 310 · see citing works
Cofactor and substrate requirements of collagen proline hydroxylase
Hutton, J. J., Tappel, A. L., & Udenfriend, S. (1967) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(67)90302-5 · Cited by 308 · see citing works
Sasaki, M., Knobbe, C. B., Itsumi, M., Elia, A. J., Harris, I. S., Chio, I. I. C., Cairns, R. A., McCracken, S., Wakeham, A., Haight, J., et al. (2012) · Genes & Development · doi:10.1101/gad.198200.112 · Cited by 296 · see citing works
Progress in understanding 2‐hydroxyglutaric acidurias
Kranendijk, M., Struys, E. A., Salomons, G. S., Van der Knaap, M. S., & Jakobs, C. (2012) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-012-9462-5 · Cited by 292 · see citing works
<scp>l</scp> -2-Hydroxyglutarate: An Epigenetic Modifier and Putative Oncometabolite in Renal Cancer
Shim, E.-H., Livi, C. B., Rakheja, D., Tan, J., Benson, D., Parekh, V., Kho, E.-Y., Ghosh, A. P., Kirkman, R., Velu, S., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0696 · Cited by 280 · see citing works
Grassian, A. R., Parker, S. J., Davidson, S. M., Divakaruni, A. S., Green, C. R., Zhang, X., Slocum, K. L., Pu, M., Lin, F., Vickers, C., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0772-t · Cited by 280 · see citing works
Loenarz, C., & Schofield, C. J. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.07.002 · Cited by 274 · see citing works
L-2-Hydroxyglutarate production arises from noncanonical enzyme function at acidic pH
Intlekofer, A. M., Wang, B., Liu, H., Shah, H., Carmona-Fontaine, C., Rustenburg, A. S., Salah, S., Gunner, M. R., Chodera, J. D., Cross, J. R., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2307 · Cited by 268 · see citing works
Li, F., He, X., Ye, D., Lin, Y., Yu, H., Yao, C., Huang, L., Zhang, J., Wang, F., Xu, S., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.10.017 · Cited by 244 · see citing works
Self-citationL‐2‐Hydroxyglutaric aciduria: an inborn error of metabolism?
Duran, M., Kamerling, J. P., Bakker, H. D., van Gennip, A. H., & Wadman, S. K. (1980) · Journal of Inherited Metabolic Disease · doi:10.1007/bf02312543 · Cited by 226 · see citing works
Lactate dehydrogenase A silencing in IDH mutant gliomas
Chesnelong, C., Chaumeil, M. M., Blough, M. D., Al-Najjar, M., Stechishin, O. D., Chan, J. A., Pieper, R. O., Ronen, S. M., Weiss, S., Luchman, H. A., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/not243 · Cited by 210 · see citing works
Wang, P., Wu, J., Ma, S., Zhang, L., Yao, J., Hoadley, K. A., Wilkerson, M. D., Perou, C. M., Guan, K.-L., Ye, D., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.11.029 · Cited by 206 · see citing works
Self-citationDiscovery of the First Potent Inhibitors of Mutant IDH1 That Lower Tumor 2-HG in Vivo
Popovici-Müller, J. V., Saunders, J. O., Salituro, F. G., Travins, J. M., Yan, S., Zhao, F., Größ, S., Dang, L., Yen, K. E., Yang, H., et al. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml300225h · Cited by 204 · see citing works
Dang, L., & Su, S.-S. M. (2017) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061516-044732 · Cited by 204 · see citing works
Chemosensitivity of IDH1-Mutated Gliomas Due to an Impairment in PARP1-Mediated DNA Repair
Lu, Y., Kwintkiewicz, J., Liu, Y., Tech, K., Frady, L. N., Su, Y.-T., Bautista, W., Moon, S. I., Macdonald, J. M., Ewend, M. G., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2773 · Cited by 203 · see citing works
Human Phosphoglycerate Dehydrogenase Produces the Oncometabolite d -2-Hydroxyglutarate
Fan, J., Teng, X., Liu, L., Mattaini, K. R., Looper, R., Heiden, M. G. V., & Rabinowitz, J. D. (2014) · ACS Chemical Biology · doi:10.1021/cb500683c · Cited by 201 · see citing works
<i>IDH2</i> Mutations in Patients with <scp>d</scp> -2-Hydroxyglutaric Aciduria
Kranendijk, M., Struys, E. A., van Schaftingen, E., Gibson, K. M., Kanhai, W. A., van der Knaap, M. S., Amiel, J., Buist, N. R., Das, A. M., de Klerk, J. B., et al. (2010) · Science · doi:10.1126/science.1192632 · Cited by 195 · see citing works
Rzem, R., Veiga-da-Cunha, M., Noël, G., Goffette, S., Nassogne, M.-C., Tabarki, B., Schöller, C., Marquardt, T., Vikkula, M., & Van Schaftingen, E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404840101 · Cited by 195 · see citing works
Inoue, S., Li, W. Y., Tseng, A., Beerman, I., Elia, A., Bendall, S. C., Lemonnier, F., Kron, K. J., Cescon, D. W., Hao, Z., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.05.018 · Cited by 194 · see citing works
New IDH1 mutant inhibitors for treatment of acute myeloid leukemia
Okoye-Okafor, U. C., Bartholdy, B., Cartier, J., Gao, E. N., Pietrak, B., Rendina, A. R., Rominger, C., Quinn, C., Smallwood, A., Wiggall, K. J., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1930 · Cited by 180 · see citing works
The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway
Carbonneau, M., M. Gagné, L., Lalonde, M.-E., Germain, M.-A., Motorina, A., Guiot, M.-C., Secco, B., Vincent, E. E., Tumber, A., Hulea, L., et al. (2016) · Nature Communications · doi:10.1038/ncomms12700 · Cited by 180 · see citing works
Pan-mutant IDH1 inhibitor BAY 1436032 for effective treatment of IDH1 mutant astrocytoma in vivo
Pusch, S., Krausert, S., Fischer, V., Balß, J., Ott, M., Schrimpf, D., Capper, D., Sahm, F., Eisel, J., Beck, A.-C., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1677-y · Cited by 174 · see citing works
Zur Kenntnis des intermediären Stoffwechsels und der dabei wirksamen Enzyme1
Thunberg, T. (1920) · Skandinavisches Archiv Für Physiologie · doi:10.1111/j.1748-1716.1920.tb01412.x · Cited by 173 · see citing works
Mutations in the d-2-Hydroxyglutarate Dehydrogenase Gene Cause d-2-Hydroxyglutaric Aciduria
Struys, E. A., Salomons, G. S., Achouri, Y., Van Schaftingen, E., Grosso, S., Craigen, W. J., Verhoeven, N. M., & Jakobs, C. (2005) · The American Journal of Human Genetics · doi:10.1086/427890 · Cited by 172 · see citing works
Hydroxyglutaric aciduria and malignant brain tumor: a case report and literature review
Aghili, M., Zahedi, F., & Rafiee, E. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-008-9706-2 · Cited by 159 · see citing works
l ‐2‐Hydroxyglutaric aciduria, a defect of metabolite repair
Rzem, R., Vincent, M., SCHAFTINGEN, E. V., & Veiga‐da‐Cunha, M. (2007) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-007-0487-0 · Cited by 149 · see citing works
Karlstaedt, A., Zhang, X., Vitrac, H., Harmancey, R., Vasquez, H., Wang, J. H., Goodell, M. A., & Taegtmeyer, H. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1601650113 · Cited by 144 · see citing works
Prognostic significance of 2-hydroxyglutarate levels in acute myeloid leukemia in China
Wang, J.-H., Chen, W., Li, J., Wu, S., Chen, T., Zhu, Y., Zhang, W., Li, Y., Qiu, Y.-P., Zhao, A.-H., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315558110 · Cited by 143 · see citing works
Acidic pH Is a Metabolic Switch for 2-Hydroxyglutarate Generation and Signaling
Nadtochiy, S. M., Schafer, X., Fu, D., Nehrke, K., Munger, J., & Brookes, P. S. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.738799 · Cited by 143 · see citing works
Nota, B., Struys, E. A., Pop, A., Jansen, E. E., Fernandez Ojeda, M. R., Kanhai, W. A., Kranendijk, M., van Dooren, S. J. M., Bevova, M. R., Sistermans, E. A., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.03.009 · Cited by 138 · see citing works
Deng, G., Shen, J., Yin, M., McManus, J., Mathieu, M., Gee, P., He, T., Shi, C., Bedel, O., McLean, L. R., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.608497 · Cited by 138 · see citing works
D‐2‐hydroxyglutaric aciduria: Case report and biochemical studies
Chalmers, R. A., Lawson, A. M., Watts, R. W. E., Tavill, A. S., Kamerling, J. P., Hey, E., & Ogilvie, D. (1980) · Journal of Inherited Metabolic Disease · doi:10.1007/bf02312516 · Cited by 135 · see citing works
Topçu, M., Jobard, F., Halliez, S., Coskun, T., Yalçinkayal, C., Gerceker, F. O., Wanders, R. J. A., Prud'homme, J.-F., Lathrop, M., Özguc, M., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh300 · Cited by 133 · see citing works
Zhao, G., & Winkler, M. E. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.1.232-239.1996 · Cited by 129 · see citing works
Identification of a dehydrogenase acting on D -2-hydroxyglutarate
Achouri, Y., NOËL, G., Vertommen, D., Rider, M. H., Veiga‐da‐Cunha, M., & SCHAFTINGEN, E. V. (2004) · Biochemical Journal · doi:10.1042/bj20031933 · Cited by 129 · see citing works
<i>IDH1</i> Mutation Induces Reprogramming of Pyruvate Metabolism
Izquierdo-Garcia, J. L., Viswanath, P., Eriksson, P., Cai, L., Radoul, M., Chaumeil, M. M., Blough, M., Luchman, H. A., Weiss, S., Cairncross, J. G., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0840 · Cited by 123 · see citing works
Colvin, H. S., Nishida, N., Konno, M., Haraguchi, N., Takahashi, H., Nishimura, J., Hata, T., Kawamoto, K., Asai, A., Tsunekuni, K., et al. (2016) · Scientific Reports · doi:10.1038/srep36289 · Cited by 108 · see citing works
Li, L., Paz, A. C., Wilky, B. A., Johnson, B. A., Galoian, K. A., Rosenberg, A. E., Hu, G., Tinoco, G., Bodamer, O. A., & Trent, J. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133813 · Cited by 107 · see citing works
Tateishi, K., Higuchi, F., Miller, J. J., Koerner, M. V. A., Lelic, N., Shankar, G. M., Tanaka, S., Fisher, D. E., Batchelor, T. T., Iafrate, A. J., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2263 · Cited by 98 · see citing works
Cloning, sequencing and expression of rat liver 3-phosphoglycerate dehydrogenase
Achouri, Y., Rider, M. H., SCHAFTINGEN, E. V., & Robbi, M. (1997) · Biochemical Journal · doi:10.1042/bj3230365 · Cited by 93 · see citing works
Davis, M. I., Größ, S., Shen, M., Straley, K. S., Pragani, R., Lea, W., Popovici-Müller, J. V., DeLaBarre, B., Artin, E., Thorne, N., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.511030 · Cited by 93 · see citing works
2-Hydroxy Acids in Plant Metabolism
Maurino, V. G., & Engqvist, M. K. M. (2015) · The Arabidopsis Book · doi:10.1199/tab.0182 · Cited by 90 · see citing works
D2HGDH regulates alpha-ketoglutarate levels and dioxygenase function by modulating IDH2
Lin, A., Abbas, S., Kim, S., Ortega, M. M., Bouamar, H., Escobedo, Y. A., Varadarajan, P., Qin, Y., Sudderth, J., Schulz, E., et al. (2015) · Nature Communications · doi:10.1038/ncomms8768 · Cited by 87 · see citing works
Chen, F., Bian, K., Tang, Q., Fedeles, B. I., Singh, V., Humulock, Z. T., Essigmann, J. M., & Li, D. (2017) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.7b00009 · Cited by 87 · see citing works
Urinary organic acids in man. I. Normal patterns.
Lawson, A. M., Chalmers, R. A., & Watts, R. W. E. (1976) · Clinical Chemistry · doi:10.1093/clinchem/22.8.1283 · Cited by 85 · see citing works
Non-enzymatic chemistry enables 2-hydroxyglutarate-mediated activation of 2-oxoglutarate oxygenases
Tarhonskaya, H., Rydzik, A. M., Leung, I. K. H., Loik, N. D., Chan, M. C., Kawamura, A., McCullagh, J. S. O., Claridge, T. D. W., Flashman, E., & Schofield, C. J. (2014) · Nature Communications · doi:10.1038/ncomms4423 · Cited by 80 · cited 4× · see citing works
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript 2-HG Can Inhibit EGLN/PHD and Collagen Hydroxylases An early study found that D-2-HG has the lowest half-maximal inhibitory concentration (IC50 = 24–106 μM) toward KDM members, followed by ABH2 (424 μM), FIH (1500 μM), PHD2 (7300 μM), and…”
BackgroundInfluentialIDH Mutation, Competitive Inhibition of FTO, and RNA Methylation
Elkashef, S. M., Lin, A.-P., Myers, J., Sill, H., Jiang, D., Dahia, P. L. M., & Aguiar, R. C. T. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.04.001 · Cited by 78 · see citing works
2-HG Inhibits Necroptosis by Stimulating DNMT1-Dependent Hypermethylation of the RIP3 Promoter
Yang, Z., Jiang, B., Wang, Y., Ni, H., Zhang, J., Xia, J., Shi, M., Hung, L.-M., Ruan, J., Mak, T. W., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.012 · Cited by 78 · see citing works
Crystallographic Investigation and Selective Inhibition of Mutant Isocitrate Dehydrogenase
Zheng, B., Yao, Y., Liu, Z., Deng, L., Anglin, J. L., Jiang, H., Prasad, B. V. V., & Song, Y. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml400036z · Cited by 76 · see citing works
Li, H., Chawla, G., Hurlburt, A. J., Sterrett, M. C., Zaslaver, O., Cox, J. E., Karty, J. A., Rosebrock, A. P., Caudy, A. A., & Tennessen, J. M. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1614102114 · Cited by 76 · see citing works
Becker‐Kettern, J., Paczia, N., Conrotte, J., Kay, D. P., Guignard, C., Jung, P. P., & Linster, C. L. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.704494 · Cited by 75 · see citing works
Isocitrate dehydrogenase mutations in leukemia
McKenney, A. S., & Levine, R. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67266 · Cited by 73 · see citing works
Chen, J.-Y., Lai, Y.-S., Tsai, H., Kuo, C.-C., Yen, B. L., Yeh, S., Sun, H. S., & Hung, W.-C. (2016) · Scientific Reports · doi:10.1038/srep32428 · Cited by 73 · see citing works
ALKBHs-facilitated RNA modifications and de-modifications
Alemu, E. A., He, C., & Klungland, A. (2016) · DNA repair · doi:10.1016/j.dnarep.2016.05.026 · Cited by 67 · see citing works
Muntau, A. C., Röschinger, W., Merkenschlager, A., van der Knaap, M. S., Jakobs, C., Durán, M., Hoffmann, G. F., & Roscher, A. (2000) · Neuropediatrics · doi:10.1055/s-2000-7497 · Cited by 66 · see citing works
A Mouse Model of L-2-Hydroxyglutaric Aciduria, a Disorder of Metabolite Repair
Rim, R., Achouri, Y., Marbaix, É., Schakman, O., Wiame, E., Marie, S., Gailly, P. L., Vincent, M., Veiga‐da‐Cunha, M., & SCHAFTINGEN, E. V. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119540 · Cited by 58 · see citing works
Nadtochiy, S. M., Urciuoli, W. R., Zhang, J., Schafer, X., Munger, J. C., & Brookes, P. S. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.09.008 · Cited by 48 · see citing works
The oxidation of l(−)α-hydroxyglutaric acid in animal tissues
Weil‐Malherbe, H. (1937) · Biochemical Journal · doi:10.1042/bj0312080 · Cited by 43 · see citing works
Struys, E. A., Verhoeven‐Duif, N. M., Brunengraber, H., & Jakobs, C. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)01459-5 · Cited by 40 · see citing works
Ma, S., Sun, R., Jiang, B., Gao, J., Deng, W., Liu, P., He, R., Cui, J., Ji, M., Yi, W., et al. (2017) · Molecular and Cellular Biology · doi:10.1128/mcb.00492-16 · Cited by 39 · see citing works
Self-citationPapillary thyroid carcinoma shows elevated levels of 2-hydroxyglutarate
Rakheja, D., Boriack, R. L., Mitui, M., Khokhar, S., Holt, S. A., & Kapur, P. (2010) · Tumor Biology · doi:10.1007/s13277-010-0125-6 · Cited by 35 · see citing works
Identification ofEscherichia coliYgaF as an l -2-Hydroxyglutarate Oxidase
Kalliri, E., Mulrooney, S. B., & Hausinger, R. P. (2008) · Journal of Bacteriology · doi:10.1128/jb.01977-07 · Cited by 34 · see citing works
Jiang, B., Zhang, J., Xia, J., Zhao, W., Wu, Y., Shi, M., Luo, L., Zhou, H., Chen, A., Ma, H., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.03.053 · Cited by 33 · see citing works
Mutations in phenotypically mild D ‐2‐hydroxyglutaric aciduria
Struys, E. A., Korman, S. H., Salomons, G. S., Darmin, P. S., Achouri, Y., SCHAFTINGEN, E. V., Verhoeven‐Duif, N. M., & Jakobs, C. (2005) · Annals of Neurology · doi:10.1002/ana.20559 · Cited by 32 · see citing works
Struys, E. A., Gibson, K. M., & Jakobs, C. (2007) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-007-0697-5 · Cited by 30 · see citing works
LOW MOLECULAR WEIGHT ORGANIC ACIDS IN THE URINE OF THE NEWBORN
Gregersen, N., Ingerslev, J. K., & Rasmussen, K. D. (1977) · Acta Paediatrica · doi:10.1111/j.1651-2227.1977.tb07812.x · Cited by 29 · see citing works
Hüdig, M., Maier, A., Scherrers, I., Seidel, L., Jansen, E. E. W., Mettler‐Altmann, T., Engqvist, M. K. M., & Maurino, V. G. (2015) · Plant and Cell Physiology · doi:10.1093/pcp/pcv108 · Cited by 27 · see citing works
Another small molecule in the oncometabolite mix: L-2-Hydroxyglutarate in kidney cancer
Shim, E., & Sudarshan, S. (2015) · Oncoscience · doi:10.18632/oncoscience.165 · Cited by 16 · see citing works
Wang, F., Travins, J. M., Lin, Z., Si, Y., Chen, Y., Powe, J., Murray, S., Zhu, D., Artin, E., Größ, S., et al. (2016) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-016-9960-y · Cited by 16 · see citing works
Ueber das Drehungsvermögen von Glutan‐ und Aepfelsäure
Ritthausen, H. (1872) · Journal für praktische Chemie · doi:10.1002/prac.18720050132 · Cited by 14 · see citing works
Ueber die Glutansäure, das Zersetzungsproduct der Glutaminsäure durch salpetrige Säure
Ritthausen, H. (1868) · Journal für praktische Chemie · doi:10.1002/prac.18681030124 · Cited by 12 · see citing works
Formation of α-Hydroxyglutaric Acid by Aspergillus glaucus
Bleiweis, A. S., Reeves, H. C., & Ajl, S. J. (1967) · Journal of Bacteriology · doi:10.1128/jb.94.5.1560-1564.1967 · Cited by 9 · see citing works
Flagged first, then by citations
2 of the 138 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Cancer metabolism: looking forward
Martínez‐Reyes, I., & Chandel, N. S. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00378-6 · Cited by 1,852 · see citing works
Metabolic reprogramming and epigenetic modifications on the path to cancer
Sun, L., Zhang, H., & Gao, P. (2021) · Protein & Cell · doi:10.1007/s13238-021-00846-7 · Cited by 796 · see citing works
The language of chromatin modification in human cancers
Zhao, S., Allis, C. D., & Wang, G. G. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00357-x · Cited by 406 · see citing works
Coupling Krebs cycle metabolites to signalling in immunity and cancer
Ryan, D. G., Murphy, M. P., Frezza, C., Prag, H. A., Chouchani, E. T., O’Neill, L. A., & Mills, E. L. (2018) · Nature Metabolism · doi:10.1038/s42255-018-0014-7 · Cited by 398 · see citing works
Metabolic signatures of cancer cells and stem cells
Intlekofer, A. M., & Finley, L. W. S. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0032-0 · Cited by 322 · see citing works
Detection and analysis of chiral molecules as disease biomarkers
Liu, Y., Wu, Z., Armstrong, D. W., Wolosker, H., & Zheng, Y. (2023) · Nature Reviews Chemistry · doi:10.1038/s41570-023-00476-z · Cited by 257 · see citing works
Sullivan, M. R., Mattaini, K. R., Dennstedt, E. A., Nguyen, A. A., Sivanand, S., Reilly, M. F., Meeth, K. M., Muir, A., Darnell, A. M., Bosenberg, M., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.02.015 · Cited by 242 · see citing works
Itaconate inhibits TET DNA dioxygenases to dampen inflammatory responses
Chen, L., Morcelle, C., Cheng, Z., Chen, X., Xu, Y., Gao, Y., Song, J., Li, Z., Smith, M. D., Shi, M., et al. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00853-8 · Cited by 228 · see citing works
Self-citationThe Mitochondrion as an Emerging Therapeutic Target in Cancer
Roth, K. G., Mambetsariev, I., Kulkarni, P., & Salgia, R. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.06.009 · Cited by 216 · see citing works
Metabolic Signaling to the Nucleus in Cancer
Campbell, S. L., & Wellen, K. E. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.07.015 · Cited by 182 · see citing works
Sex Differences in Intestinal Carbohydrate Metabolism Promote Food Intake and Sperm Maturation
Hudry, B., de Goeij, E., Mineo, A., Gaspar, P., Hadjieconomou, D., Studd, C., Mokochinski, J. B., Kramer, H., Plaçais, P.-Y., Préat, T., et al. (2019) · Cell · doi:10.1016/j.cell.2019.07.029 · Cited by 159 · see citing works
Tommasini-Ghelfi, S., Murnan, K., Kouri, F. M., Mahajan, A., May, J., & Stegh, A. H. (2019) · Science Advances · doi:10.1126/sciadv.aaw4543 · Cited by 166 · see citing works
HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells
Lee, S.-H., Golinska, M., & Griffiths, J. R. (2021) · Cells · doi:10.3390/cells10092371 · Cited by 169 · see citing works
Current and emerging therapies for advanced biliary tract cancers
Kam, A. E., Masood, A., & Shroff, R. T. (2021) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(21)00171-0 · Cited by 167 · see citing works
Metabolic remodelling during early mouse embryo development
Zhao, J., Yao, K., Yu, H., Zhang, L., Xu, Y., Chen, L., Sun, Z., Zhu, Y., Zhang, C., Qian, Y., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00464-x · Cited by 164 · see citing works
Wu, M., Shi, L., Dubrot, J., Merritt, J., Vijay, V., Wei, T.-Y., Kessler, E., Olander, K. E., Adil, R., Pankaj, A., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-1077 · Cited by 157 · see citing works
The Roles of 2-Hydroxyglutarate
Du, X., & Hu, H. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.651317 · Cited by 152 · see citing works
TET Enzymes and 5hmC in Adaptive and Innate Immune Systems
Lio, C. J., & Rao, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00210 · Cited by 139 · see citing works
Cancer metabolism and tumor microenvironment: fostering each other?
Yuan, Y., Li, H., Wang, P., Chen, L., Guo, D. S., Jiang, H., He, B., Qin, S., Wang, K., Li, N., et al. (2021) · Science China Life Sciences · doi:10.1007/s11427-021-1999-2 · Cited by 138 · see citing works
Self-citationMitochondrial metabolism supports resistance to IDH mutant inhibitors in acute myeloid leukemia
Stuani, L., Sabatier, M., Wang, F., Poupin, N., Bosc, C., Saland, E., Castelli, F. A., Gales, L., Montersino, C., Boët, E., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20200924 · Cited by 131 · see citing works
Tan, M., Mosaoa, R., Graham, G. T., Kasprzyk-Pawelec, A., Gadre, S. M., Parasido, E., Catalina-Rodriguez, O., Foley, P. L., Giaccone, G., Cheema, A. K., et al. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-0491-6 · Cited by 131 · see citing works
2-Hydroxyglutarate in Cancer Cells
Ježek, P. (2020) · Antioxidants & Redox Signaling · doi:10.1089/ars.2019.7902 · Cited by 130 · see citing works
Reprogramming of serine, glycine and one-carbon metabolism in cancer
Li, A. M., & Ye, J. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165841 · Cited by 127 · see citing works
Muir, A., Danai, L. V., & Heiden, M. G. V. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.035758 · Cited by 121 · see citing works
Two genomes, one cell: Mitochondrial-nuclear coordination via epigenetic pathways
Wiese, M., & Bannister, A. J. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.01.006 · Cited by 116 · see citing works
Kaminska, B., Czapski, B., Guzik, R., Król, S. K., & Gielniewski, B. (2019) · Molecules · doi:10.3390/molecules24050968 · Cited by 110 · see citing works
Oh, S., Yeom, J., Cho, H. J., Kim, J.-H., Yoon, S., Kim, H.-D., Sa, J. K., Ju, S., Lee, H., Oh, M. J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17139-y · Cited by 100 · see citing works
Widespread bacterial lysine degradation proceeding via glutarate and L-2-hydroxyglutarate
Knorr, S., Sinn, M., Galetskiy, D., Williams, R. M., Wang, C., Müller, N., Mayans, O. M., Schleheck, D., & Hartig, J. S. (2018) · Nature Communications · doi:10.1038/s41467-018-07563-6 · Cited by 97 · see citing works
The oncometabolite 2-hydroxyglutarate produced by mutant IDH1 sensitizes cells to ferroptosis
Wang, T., Liang, J.-Y., Zhang, C., Xiong, Y., Guan, K., & Yuan, H. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1984-4 · Cited by 104 · see citing works
Self-citationAn LKB1–mitochondria axis controls TH17 effector function
Baixauli, F., Piletič, K., Puleston, D. J., Villa, M., Field, C. S., Flachsmann, L. J., Quintana, A., Rana, N., Edwards-Hicks, J., Matsushita, M., et al. (2022) · Nature · doi:10.1038/s41586-022-05264-1 · Cited by 100 · see citing works
Defining a metabolic landscape of tumours: genome meets metabolism
Nanda, C. S., Venkateswaran, S. V., Patani, N., & Yuneva, M. O. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0663-7 · Cited by 94 · see citing works
Mitochondrial and metabolic alterations in cancer cells
Gregorio, J. D., Petricca, S., Iorio, R., Toniato, E., & Flati, V. (2022) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2022.151225 · Cited by 93 · see citing works
The Role of D-3-Phosphoglycerate Dehydrogenase in Cancer
Zhao, X., Fu, J., Du, J., & Xu, W. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.41051 · Cited by 90 · see citing works
Role of Metabolism in Bone Development and Homeostasis
Suzuki, A., Minamide, M., Iwaya, C., Ogata, K., & Iwata, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238992 · Cited by 90 · see citing works
Recent advances of IDH1 mutant inhibitor in cancer therapy
Tian, W., Zhang, W., Wang, Y., Jin, R., Wang, Y., Guo, H., Tang, Y., & Yao, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.982424 · Cited by 88 · see citing works
Walsby-Tickle, J., Gannon, J. M., Hvinden, I. C., Bardella, C., Abboud, M. I., Nazeer, A., Hauton, D., Pires, E., Cadoux-Hudson, T. A. D., Schofield, C. J., et al. (2020) · Communications Biology · doi:10.1038/s42003-020-0957-6 · Cited by 78 · see citing works
Aging: All roads lead to mitochondria
Son, J. M., & Lee, C. D. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.02.006 · Cited by 82 · see citing works
Mosaoa, R., Kasprzyk-Pawelec, A., Fernandez, H. R., & Avantaggiati, M. L. (2021) · Biomolecules · doi:10.3390/biom11020141 · Cited by 76 · see citing works
The Tricarboxylic Acid Cycle at the Crossroad Between Cancer and Immunity
Scagliola, A., Mainini, F., & Cardaci, S. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7974 · Cited by 73 · see citing works
Metabolites are not genes — avoiding the misuse of pathway analysis in metabolomics
Lee, K. S., Su, X., & Huan, T. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01283-0 · Cited by 75 · see citing works
Itaconate in host inflammation and defense
Ye, D., Wang, P., Chen, L., Guan, K., & Xiong, Y. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.02.004 · Cited by 71 · see citing works
Self-citationAstrocytoma: A Hormone-Sensitive Tumor?
Hirtz, A., Rech, F., Dubois‐Pot‐Schneider, H., & Dumond, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239114 · Cited by 69 · see citing works
IDH1/IDH2 Inhibition in Acute Myeloid Leukemia
Cerchione, C., Romano, A., Daver, N. G., Dinardo, C. D., Jabbour, E. J., Konopleva, M. Y., Ravandi‐Kashani, F., Kadia, T. M., Martelli, M. P., Isidori, A., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.639387 · Cited by 69 · see citing works
Differentiating enantiomers by directional rotation of ions in a mass spectrometer
Zhou, X., Wang, Z., Li, S., Rong, X., Bu, J., Liu, Q., & Ouyang, Z. (2024) · Science · doi:10.1126/science.adj8342 · Cited by 68 · see citing works
Cellular Compartmentation and the Redox/Nonredox Functions of NAD +
Kulkarni, C. A., & Brookes, P. S. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2018.7722 · Cited by 64 · see citing works
Dual mechanisms of posttranscriptional regulation of Tet2 by Let-7 microRNA in macrophages
Jiang, S., Yan, W., Wang, S. E., & Baltimore, D. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1811040116 · Cited by 63 · see citing works
Metabolic Rewiring in Glioblastoma Cancer: EGFR, IDH and Beyond
Khayari, A. E., Bouchmaa, N., Taïb, B., Wei, Z., Zeng, A., & Fatimy, R. E. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.901951 · Cited by 62 · see citing works
Oncometabolites as biomarkers in thyroid cancer: a systematic review
Khatami, F., Payab, M., Sarvari, M., Gilany, K., Larijani, B. A., Arjmand, B., & Tavangar, S. M. (2019) · Cancer Management and Research · doi:10.2147/cmar.s188661 · Cited by 58 · see citing works
Therapeutic Targeting of Cancer Stem Cells: Integrating and Exploiting the Acidic Niche
Linden, C. V., & Corbet, C. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00159 · Cited by 58 · see citing works
Glutamine metabolism in Th17/Treg cell fate: applications in Th17 cell-associated diseases
Yang, G., Xia, Y., & Ren, W. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1703-2 · Cited by 55 · see citing works
Metabolic adaptations in cancers expressing isocitrate dehydrogenase mutations
Hvinden, I. C., Cadoux-Hudson, T. A. D., Schofield, C. J., & McCullagh, J. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100469 · Cited by 59 · see citing works
Williams, N. C., Ryan, D. G., Costa, A. S. H., Mills, E. L., Jedrychowski, M. P., Cloonan, S. M., Frezza, C., & O'Neill, L. A. J. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101501 · Cited by 56 · see citing works
Metabolic regulation in the immune response to cancer
Wu, Q., Yu, X., Li, J., Sun, S., & Tu, Y. (2021) · 癌症：英文版 · doi:10.1002/cac2.12182 · Cited by 56 · see citing works
Endogenous toxic metabolites and implications in cancer therapy
Lee, N., Spears, M. E., Carlisle, A. E., & Kim, D. (2020) · Oncogene · doi:10.1038/s41388-020-01395-9 · Cited by 54 · see citing works
Wild-Type IDH Enzymes as Actionable Targets for Cancer Therapy
Bergaggio, E., & Piva, R. (2019) · Cancers · doi:10.3390/cancers11040563 · Cited by 52 · see citing works
Chalifoux, O., Faerman, B., & Mailloux, R. J. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105399 · Cited by 51 · see citing works
Bodywide ecological interventions on cancer
Kroemer, G., McQuade, J. L., Mérad, M., André, F., & Zitvogel, L. (2023) · Nature Medicine · doi:10.1038/s41591-022-02193-4 · Cited by 51 · see citing works
Oncometabolites in cancer aggressiveness and tumour repopulation
Dando, I., Pozza, E. D., Ambrosini, G., Torrens‐Mas, M., Butera, G., Mullappilly, N., Pacchiana, R., Palmieri, M., & Donadelli, M. (2019) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12513 · Cited by 49 · see citing works
Wang, R., Zhuang, J., Zhang, Q., Wu, W., Yu, X., Zhang, H., & Xie, Z. (2025) · Experimental Hematology and Oncology · doi:10.1186/s40164-025-00689-6 · Cited by 51 · see citing works
Gao, Y., Zimmer, J. T., Vasic, R., Liu, C., Gbyli, R., Zheng, S.-J., Patel, A. J., Liu, W., Qi, Z., Li, Y., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113163 · Cited by 46 · see citing works
Metabolite regulation of epigenetics in cancer
Wang, P., Chen, L., Xiong, Y., & Ye, D. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114815 · Cited by 48 · see citing works
Self-citationPresti, C. L., Fauvelle, F., Jacob, M., Mondet, J., & Mossuz, P. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020002981 · Cited by 45 · see citing works
Rawat, V., Malvi, P., Della Manna, D., Yang, E. S., Bugide, S., Zhang, X., Gupta, R., & Wajapeyee, N. (2021) · Oncogene · doi:10.1038/s41388-021-01683-y · Cited by 43 · see citing works
Regulation of Metabolic Homeostasis in Cell Culture Bioprocesses
O’Brien, C. M., Mulukutla, B. C., Mashek, D. G., & Hu, W. (2020) · Trends in biotechnology · doi:10.1016/j.tibtech.2020.02.005 · Cited by 43 · see citing works
de Goede, K. E., Harber, K. J., Gorki, F. S., Verberk, S. G. S., Groh, L. A., Keuning, E. D., Struys, E. A., van Weeghel, M., Haschemi, A., de Winther, M. P. J., et al. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166427 · Cited by 42 · see citing works
IDH1 p.R132H ctDNA and D-2-hydroxyglutarate as CSF biomarkers in patients with IDH-mutant gliomas
Fujita, Y., Nunez-Rubiano, L., Dono, A., Bellman, A., Shah, M., Rodrı́guez, J. C., Putluri, V., Kamal, A. H. M., Putluri, N., Riascos, R., et al. (2022) · Journal of Neuro-Oncology · doi:10.1007/s11060-022-04060-1 · Cited by 39 · see citing works
Fletcher, S. C., & Coleman, M. L. (2020) · Biochemical Society Transactions · doi:10.1042/bst20190333 · Cited by 42 · see citing works
Mitochondrial DNA Alterations in Glioblastoma (GBM)
Barros, M. B. L., Pinheiro, D. D. R., & Borges, B. D. N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115855 · Cited by 42 · see citing works
Protein Kinase B (PKB/AKT) Protects IDH-Mutated Glioma from Ferroptosis via Nrf2
Liu, Y., Chou, F.-J., Lang, F., Zhang, M., Song, H., Zhang, W., Davis, D. L., Briceno, N., Zhang, Y., Cimino, P. J., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-3179 · Cited by 41 · see citing works
Metabolic profiling in children and young adults with autosomal dominant polycystic kidney disease
Baliga, M. M., Klawitter, J., Christians, U., Hopp, K., Chonchol, M., Gitomer, B. Y., Cadnapaphornchai, M. A., & Klawitter, J. (2021) · Scientific Reports · doi:10.1038/s41598-021-84609-8 · Cited by 41 · see citing works
Borde, S., & Matosevic, S. (2023) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2023.08.009 · Cited by 41 · see citing works
Whole-genome analysis of TET dioxygenase function in regulatory T cells
Yue, X., Samaniego‐Castruita, D., González‐Avalos, E., Li, X., Barwick, B. G., & Rao, A. (2021) · EMBO Reports · doi:10.15252/embr.202152716 · Cited by 40 · see citing works
An l-2-hydroxyglutarate biosensor based on specific transcriptional regulator LhgR
Kang, Z., Zhang, M., Gao, K., Zhang, W., Meng, W., Liu, Y., Xiao, D., Guo, S., Ma, C., Gao, C., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23723-7 · Cited by 41 · see citing works
Sipari, N., Lihavainen, J., Shapiguzov, A., Kangasjärvi, J., & Keinänen, M. (2020) · Frontiers in Plant Science · doi:10.3389/fpls.2020.00194 · Cited by 38 · see citing works
Lafita‐Navarro, M. C., Perez‐Castro, L., Zacharias, L. G., Barnes, S. D., DeBerardinis, R. J., & Conacci‐Sorrell, M. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ac120.014189 · Cited by 37 · see citing works
Magnetic resonance spectroscopy for the study of cns malignancies
Ruiz‐Rodado, V., Brender, J., Cherukuri, M. K., Gilbert, M. R., & Larion, M. (2020) · Progress in Nuclear Magnetic Resonance Spectroscopy · doi:10.1016/j.pnmrs.2020.11.001 · Cited by 37 · see citing works
A d-2-hydroxyglutarate biosensor based on specific transcriptional regulator DhdR
Xiao, D., Zhang, W., Guo, X., Liu, Y., Hu, C., Guo, S., Kang, Z., Xu, X., Ma, C., Gao, C., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27357-7 · Cited by 34 · see citing works
Evolving Treatment Strategies for Elderly Leukemia Patients with IDH Mutations
Buege, M. J., DiPippo, A. J., & Dinardo, C. D. (2018) · Cancers · doi:10.3390/cancers10060187 · Cited by 35 · see citing works
Ahuja, S., & Zaheer, S. (2025) · Immunology · doi:10.1111/imm.70045 · Cited by 39 · see citing works
Inhibitors of Mutant Isocitrate Dehydrogenases 1 and 2 (mIDH1/2): An Update and Perspective
Ma, T., Zou, F., Pusch, S., Xu, Y., von Deimling, A., & Zha, X. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00159 · Cited by 35 · see citing works
Harnessing Lactate Metabolism for Radiosensitization
Liu, K. X., Everdell, E., Pal, S., Haas-Kogan, D. A., & Milligan, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.672339 · Cited by 36 · see citing works
A comprehensive review on signaling attributes of serine and serine metabolism in health and disease
Wu, D., Zhang, K., Khan, F. A., Pandupuspitasari, N. S., Guan, K., Sun, F., & Huang, C. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.129607 · Cited by 33 · see citing works
Self-citationYang, J., Zhu, H., Zhang, T., & Ding, J. (2021) · Cell Discovery · doi:10.1038/s41421-020-00227-0 · Cited by 32 · see citing works
Regulation of tumor metabolism by post translational modifications on metabolic enzymes
Dessai, A. S., Kalhotra, P., Novickis, A. T., & Dasgupta, S. (2022) · Cancer Gene Therapy · doi:10.1038/s41417-022-00521-x · Cited by 36 · see citing works
Li, A. M., & Ye, J. (2023) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-062822-120857 · Cited by 31 · see citing works
Rapid diagnosis of IDH1-mutated gliomas by 2-HG detection with gas chromatography mass spectrometry
Xu, H., Xia, Y., Li, C., Zhang, J., Liu, Y., Wei, Y., Qin, Z., Chen, L., Shi, Z., Quan, K., et al. (2018) · Laboratory Investigation · doi:10.1038/s41374-018-0163-z · Cited by 32 · see citing works
Self-citationIvosidenib in IDH1-mutated cholangiocarcinoma: Clinical evaluation and future directions
Lavacchi, D., Caliman, E., Rossi, G., Buttitta, E., Botteri, C., Fancelli, S., Pellegrini, E., Roviello, G., Pillozzi, S., & Antonuzzo, L. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108170 · Cited by 32 · see citing works
Isocitrate dehydrogenase 3b is required for spermiogenesis but dispensable for retinal viability
Zhu, S., Huang, J., Xu, R., Wang, Y., Wan, Y., McNeel, R., Parker, E. D., Kolson, D. R., Yam, M., Webb, B. A., et al. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102387 · Cited by 34 · see citing works
Crispo, F., Pietrafesa, M., Condelli, V., Maddalena, F., Bruno, G., Piscazzi, A., Sgambato, A., Esposito, F., & Landriscina, M. (2020) · Molecules · doi:10.3390/molecules25163754 · Cited by 32 · see citing works
Targeting Isocitrate Dehydrogenase (IDH) in Solid Tumors: Current Evidence and Future Perspectives
Carosi, F., Broseghini, E., Fabbri, L., Corradi, G., Gili, R., Forte, V., Roncarati, R., Filippini, D. M., & Ferracin, M. (2024) · Cancers · doi:10.3390/cancers16152752 · Cited by 31 · see citing works
MYC Regulation of D2HGDH and L2HGDH Influences the Epigenome and Epitranscriptome
Qiu, Z., Lin, A., Jiang, S., Elkashef, S. M., Myers, J., Srikantan, S., Sasi, B. K., Cao, J. Z., Godley, L. A., Rakheja, D., et al. (2020) · Cell chemical biology · doi:10.1016/j.chembiol.2020.02.002 · Cited by 30 · see citing works
Sun, X., Berger, R. S., Heinrich, P., Marchiq, I., Pouysségur, J., Renner, K., Oefner, P. J., & Dettmer, K. (2020) · Metabolites · doi:10.3390/metabo10070292 · Cited by 29 · see citing works
Fan, B., Dai, D., Dinardo, C. D., Stein, E. M., de Botton, S., Attar, E. C., Liu, H., Liu, G., Lemieux, I. R., Agresta, S. V., et al. (2020) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-020-04064-6 · Cited by 28 · see citing works
Isocitrate dehydrogenase gene variants in cancer and their clinical significance
Cadoux-Hudson, T. A. D., Schofield, C. J., & McCullagh, J. (2021) · Biochemical Society Transactions · doi:10.1042/bst20210277 · Cited by 27 · see citing works
5-methylcytosine turnover: Mechanisms and therapeutic implications in cancer
Turpin, M., & Salbert, G. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.976862 · Cited by 28 · see citing works
Li, H., Hurlburt, A. J., & Tennessen, J. M. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.035337 · Cited by 26 · see citing works
Metabolic Reprogramming of Mouse Bone Marrow Derived Macrophages Following Erythrophagocytosis
Catala, A., Youssef, L. A., Reisz, J. A., Dzieciątkowska, M., Powers, N. E., Marchetti, C., Karafin, M. S., Zimring, J. C., Hudson, K. E., Hansen, K. C., et al. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00396 · Cited by 26 · see citing works
Lin, A.-P., Qiu, Z., Ethiraj, P., Sasi, B., Jaafar, C., Rakheja, D., & Aguiar, R. C. T. (2022) · Leukemia · doi:10.1038/s41375-021-01489-7 · Cited by 25 · see citing works
Kusi, M., Zand, M., Lin, L., Chen, M., Lopez, A., Lin, C.-L., Wang, C., Lucio, N. L. L., Kirma, N. B., Ruan, J., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2021.110220 · Cited by 25 · see citing works
Metabolic challengers selecting tumor-persistent cells
Mancini, C., Lori, G., Pranzini, E., & Taddei, M. L. (2023) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2023.11.005 · Cited by 25 · see citing works
- Authors
- Ye, D., Guan, K.-L., & Xiong, Y.
- Affiliations
- Shanghai Medical College of Fudan University (CN)
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Ye, Dan
- Xiong, Yue
- Venue
- Trends in Cancer
- Publisher
- Elsevier BV
- Published
- 2018-02
- Volume
- 4
- Issue
- 2
- Pages
- 151-165
- ISSN
- 2405-8025 (ISSN-L)
- 2405-8033
- PMC
- PMC5884165
- OpenAlex
- W2782192099
- Cited by
- 242
- References
- 138
- Citations by year
- 2026: 26 · 2025: 31 · 2024: 23 · 2023: 28 · 2022: 30 · 2021: 38 · 2020: 29 · 2019: 25 · 2018: 11 · 2014: 1
- FWCI
- 2.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Trends in cancer (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion, cc-by-nc-nd)
- PubMed Central (acceptedVersion, cc-by-nc-nd)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by-nc-nd)
- Funders
- National Key R&D Program of China (2016YFA0501800)
- NSFC (81522033, 81372198)
- Shanghai Committee of Science and Technology (16JC1404000)
- NIH (CA196878, GM51586, CA063834, CA163834)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Biochemical Acid Research Studies
- Health Sciences › Medicine › Genetics › Glioma Diagnosis and Treatment
- Keywords
- 2-hydroxyglutarate, IDH mutation, IDH1, IDH2, alpha-ketoglutarate, epigenetic demethylation, histone demethylation, DNA demethylation, hypoxia, acidosis
- MeSH terms
- Animals, Glutarates, Humans, Isocitrate Dehydrogenase, Mutation, Neoplasms, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
